There is an increased demand and shortage in Canada for Cisatracurium Besylate Injection, as a result of the COVID-19 pandemic. Given the medical necessity of this product in Canada, and to maintain a continued supply, Health Canada has authorized a temporary colour change of the ferrule (metal seal) from teal to red , for Cisatracurium Omega Multi-Dose (Cisatracurium Besylate Injection) 20 mg/10mL (2 mg/mL) 10 mL vials. This temporary change is due to delays in receiving the caps with a teal ferrule and will remain in place until additional inventory is received by Omega.
RecallTracker